Pfizer stock

Article Index

Stock Market Today: Data Breach Hits Second-Largest U.S. Health Insurer

By , Executive Producer, Money Morning -

Stock market today

Stock market today, February 5, 2015: Stock market futures for Thursday, Feb. 5, showed a 77-point increase from yesterday's close. On Wednesday, the Dow Jones erased a 100-point gain to end the day just 6 points higher than where it started. Investors turned cautious as oil prices fell once again.

The stock market today opens with news that hackers struck Anthem Inc (Nasdaq: ANTM) - the second-largest health insurer in the U.S.

Today's biggest news will come from Europe. The European Central Bank abruptly canceled an agreement that would exchange Greek bonds for new funding. This will require the Greek Central Bank to pump money into its banking system with emergency liquidity over the next two months.

Here's what else you should know about the stock market today - including your "Money Morning Tip of the Day" - to make it a profitable Thursday...

Trouble Ahead for Pfizer Stock (NYSE: PFE) as Lipitor Claims Inevitably Amass

By , Associate Editor, Money Morning • @TaraKateClarke -

pfizer stock

Updated August 14, 2014: Pfizer stock (NYSE: PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer's blockbuster drug Lipitor - the world's best-selling drug of all time - causes type-2 diabetes in women.

"This will be a huge overhang on Pfizer stock," Money Morning Capital Wave Strategist Shah Gilani said. "Investors have to watch developments closely."

With a market cap of more than $180 billion, the world's largest pharmaceutical firm's pockets run deep. Lipitor alone brought in global sales of more than $125 billion for Pfizer over the 14-and-a-half years since its 1996 market debut (Pfizer's patent on Lipitor expired on November 30, 2011). More than 29 million patients took the drug just in the United States.

Here’s why there’s a recent spike in claims, and how Gilani recommends playing PFE stock in coming months…

Today's Stock Market News Abuzz from Brewing Lawsuit Over PFE's Lipitor

By , Executive Producer, Money Morning -

today's stock market news

Today's stock market news, August 8, 2014: U.S. stocks fell sharply in the final hour of trading Thursday despite declining jobless claims in the U.S. economy.

On Thursday, Moscow banned most food imports from Western nations in response to heightened economic sanctions. The deal isolates Russians from global trade to a level that hasn't been seen since the end of the Cold War, with specific imports from the United States, Australia, Canada, the European Union, and Norway banned.

Here are the top stories in stock market news today...

AstraZeneca Deal Is the Boost Pfizer (NYSE: PFE) Stock Needs

By , Associate Editor, Money Morning • @KyleAndersonMM -

British pharmaceutical company AstraZeneca Plc (NYSE: AZN) once again rebuffed a takeover bid from rival Pfizer Inc. (NYSE: PFE) today (Tuesday) when the company announced its forward strategy and revenue projections.

But the Pfizer AstraZeneca deal is too important for Pfizer to give up on. Because of AZN's huge upcoming pipeline, it could help PFE stock regain the momentum that it's been missing.

But an expanded drug pipeline isn’t the only reason this deal makes sense for Pfizer and for PFE stock…